First national clinical trial to investigate treatments for prescription opioid use disorder

The University of Montreal Hospital Research Centre and the Canadian Research Initiative in Substance Misuse (CRISM), in collaboration with many Canadian partners, have launched the first-ever national clinical trial to study how patients respond to different treatments for prescription opioid use disorder, with the goal of improving treatment outcomes. 

Cystic fibrosis: discovery of a key molecule for improving treatments

Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have identified a promising solution to improving treatments offered to patients with cystic fibrosis. 

This advancement, published in Frontiers in Cellular and Infection Microbiology, could lead to the development of new personalized therapies in the near future.

Can genetics and genomics truly contribute to drug target identification and precision medicine?

On December 15th, 2017, the CRCHUM Conferences invites John D. Rioux, professor of medicine at University of Montreal and Montreal Heart Institute, CRC in Genetics and Genomic Medicine. During this conference he will focus on the inflammatory bowel diseases such as Crohn’s Disease and ulcerative colitis.

Developing a new drug for orphan CNS disorders: the path from benchside to clinic

On December 8th, 2017, the CRCHUM Conferences invites Lisa McKerracher, Founder and CEO, BioAxone BioSciences and Adjunct Professor, Department of Neurology and Neurosurgery at McGill University. During this conference she will review bed to bedside translation of their lead drug, a biologic drug to treat acute spinal cord injury.

Pediatric Type 2 Diabetes in Canada - DREAMing of ways to Curb the Crisis

On December 1st, 2017, the CRCHUM Conferences invites Jon McGavock, Associate Professor, Department of Pediatrics, Faculty of Health Sciences, University of Manitoba. He will discuss during his talk the current state of science with regards to prevent and management of type 2 diabetes and it’s complications and examine the translational work conducted.


Subscribe to CRCHUM RSS